ARS Pharmaceuticals, Inc. (SPRY)
2.96
-0.40
(-11.90%)
USD |
NASDAQ |
Nov 20, 16:00
2.95
-0.01
(-0.34%)
After-Hours: 20:00
ARS Pharmaceuticals Total Assets (Quarterly) : 251.48M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 251.48M |
| June 30, 2026 | 249.50M |
| March 31, 2026 | 287.57M |
| December 31, 2025 | 327.65M |
| September 30, 2025 | 372.80M |
| June 30, 2025 | 313.47M |
| March 31, 2025 | 327.32M |
| December 31, 2024 | 351.15M |
| September 30, 2024 | 217.60M |
| June 30, 2024 | 221.97M |
| March 31, 2024 | 227.58M |
| December 31, 2023 | 233.19M |
| September 30, 2023 | 248.56M |
| June 30, 2023 | 258.75M |
| Date | Value |
|---|---|
| March 31, 2023 | 271.19M |
| December 31, 2022 | 281.44M |
| September 30, 2022 | 271.06M |
| June 30, 2022 | 294.00M |
| March 31, 2022 | 312.47M |
| December 31, 2021 | 61.45M |
| September 30, 2021 | 352.56M |
| June 30, 2021 | 366.98M |
| March 31, 2021 | 382.20M |
| December 31, 2020 | 394.80M |
| September 30, 2020 | 148.91M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 15.65M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | 330.37M |
| Sionna Therapeutics, Inc. | 263.26M |
| Ardelyx, Inc. | 587.52M |
| Compass Therapeutics, Inc. | 174.50M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 263.44M |
| Shareholders Equity (Quarterly) | -11.96M |
| Debt to Equity Ratio | -10.19 |
| Current Ratio | 3.251 |
| Net Debt Paydown Yield | -5.56% |